Transplantation-related adverse events
Adverse events . | No. . |
|---|---|
| Early: within 2 mo | |
| Fever | 16 |
| FUO (documented sepsis) | 11 (5) |
| CMV reactivation (symptomatic) | 6 (5) |
| Urinary tract infection | 3 |
| Enteritis | 3 |
| Transient increase in AST/ALT levels | 1 |
| Gastric ulcer bleeding | 1 |
| Late: between 2 and 4 mo | |
| HVZ infection | 2 |
| Transient monoclonal gammopathy | 3 |
Adverse events . | No. . |
|---|---|
| Early: within 2 mo | |
| Fever | 16 |
| FUO (documented sepsis) | 11 (5) |
| CMV reactivation (symptomatic) | 6 (5) |
| Urinary tract infection | 3 |
| Enteritis | 3 |
| Transient increase in AST/ALT levels | 1 |
| Gastric ulcer bleeding | 1 |
| Late: between 2 and 4 mo | |
| HVZ infection | 2 |
| Transient monoclonal gammopathy | 3 |
FUO indicates fever of unknown origin; HVZ, herpes varicella zoster.